{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:49Z","timestamp":1790796229101,"version":"4.1.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,8,7]]},"DOI":"10.18632\/oncotarget.4146","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:28:55Z","timestamp":1442298535000},"page":"19204-19216","source":"Crossref","is-referenced-by-count":114,"title":["Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile"],"prefix":"10.18632","volume":"6","author":[{"given":"Lourdes","family":"Mart\u00edn-Mart\u00edn","sequence":"first","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Vidriales","sequence":"additional","affiliation":[{"name":"Hematology Department and IBSAL, University Hospital of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Caballero","sequence":"additional","affiliation":[{"name":"Hematology Department and IBSAL, University Hospital of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio Silva","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital de Santo Ant\u00f3nio dos Capuchos, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia In\u00eas","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Santa Luzia Medical Laboratory, Florian\u00f3polis, SC, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Lima","sequence":"additional","affiliation":[{"name":"Clinical Hematology Department, Hospital de Santo Ant\u00f3nio, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Universidade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Valverde","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Nacional de Ni\u00f1os Dr. Carlos S\u00e1enz Herrera, San Jos\u00e9, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital del Mar, Barcelona. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Candeias","sequence":"additional","affiliation":[{"name":"Immunology Department, Hospital S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ru\u00edz-Cabello","sequence":"additional","affiliation":[{"name":"Clinical Analysis and Immunology Department, Hospital Virgen de las Nieves, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa Marco","family":"Buadesa","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital General de Castell\u00f3n, Castell\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Sempere","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital La F\u00e9, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Villamor","sequence":"additional","affiliation":[{"name":"Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Almeida","sequence":"additional","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,5,25]]},"reference":[{"key":"1","first-page":"58","article-title":"Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies","volume":"89","author":"Orfao","year":"2004","journal-title":"Haematologica"},{"key":"2","first-page":"145","volume-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","author":"Petrella","year":"2008","edition":"4"},{"key":"3","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Jacob","year":"2001","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2011-03-337501","article-title":"Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion","volume":"118","author":"Paulli","year":"2011","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Pisano","year":"2014","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.leukres.2009.09.006","article-title":"Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group","volume":"34","author":"Rontogianni","year":"2010","journal-title":"Leuk Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"D'Arco","year":"2013","journal-title":"Haematologica"},{"key":"8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Jones","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"9","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":"Novel markers of normal and neoplastic human plasmacytoid dendritic cells","volume":"111","author":"Isaacson","year":"2008","journal-title":"Blood"},{"key":"10","first-page":"1256","article-title":"Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells","volume":"105","author":"Seilles","year":"2005","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Foisseaud","year":"2009","journal-title":"British journal of haematology"},{"key":"12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2133.2004.06296.x","article-title":"CD56-negative blastic natural killer-cell lymphoma (agranular CD4(+)\/CD56(+) haematodermic neoplasm)?","volume":"152","author":"Kawai","year":"2005","journal-title":"The British journal of dermatology"},{"key":"13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2012-08-447599","article-title":"SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms","volume":"121","author":"Piris","year":"2013","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.18632\/oncotarget.2223","article-title":"Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm","volume":"5","author":"Anagnostopoulos","year":"2014","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjd.12412","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients","volume":"169","author":"Barete","year":"2013","journal-title":"The British journal of dermatology"},{"key":"16","first-page":"920","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"2","author":"Staudt","year":"2002","journal-title":"Nature reviews"},{"key":"17","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/1097-0142(19950515)75:10<2474::AID-CNCR2820751013>3.0.CO;2-Y","article-title":"Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic andculture with inducing agents","volume":"75","author":"Loughran","year":"1995","journal-title":"Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-131-7-199910050-00035","article-title":"CD123 hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma","volume":"131","author":"Orfao","year":"1999","journal-title":"Ann Intern Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1537-2995.2009.02170.x","article-title":"Immunophenotypical, morphologic, and functional characterization of maturation-associated plasmacytoid dendritic cell subsets in normal adult human bone marrow","volume":"49","author":"Orfao","year":"2009","journal-title":"Transfusion"},{"key":"20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2249.1999.01078.x","article-title":"Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+\/lineage- cells","volume":"118","author":"Orfao","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jaffe","year":"2010","journal-title":"Haematologica"},{"key":"22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Le Calvez","year":"2002","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Frizzera","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment","volume":"98","author":"Gaugler","year":"2001","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Bernard","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"121","author":"Rocha","year":"2013","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0609.2010.01466.x","article-title":"High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents","volume":"85","author":"Dimopoulos","year":"2010","journal-title":"Eur J Haematol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.1989.7.10.1518","article-title":"A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels","volume":"7","author":"Cabanillas","year":"1989","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":"Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients","volume":"124","author":"Rowinsky","year":"2014","journal-title":"Blood"},{"key":"30","first-page":"1261","article-title":"Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies","volume":"86","author":"Sierra","year":"2001","journal-title":"Haematologica"},{"key":"31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1200\/JCO.2013.52.2425","article-title":"Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial","volume":"32","author":"Cladera","year":"2014","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"Sedek","year":"2012","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T03:59:14Z","timestamp":1718078354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,25]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015,8,7]]}},"alternative-id":["4146","26056082"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4146","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,25]]}}}